{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:19:54Z","timestamp":1786994394956,"version":"build-2736575974"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.mrfmmm.2003.11.015","type":"journal-article","created":{"date-parts":[[2004,4,21]],"date-time":"2004-04-21T04:14:02Z","timestamp":1082520842000},"page":"101-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro"],"prefix":"10.1016","volume":"549","author":[{"given":"Larry D","family":"Kier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Neft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Suizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tari","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Onsurez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Tiegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Sankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert P","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/50.1.1","article-title":"Concise review: gene expression applied to toxicology","volume":"50","author":"Farr","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB2","first-page":"41","article-title":"Genomic biomarkers of toxicity","volume":"6","author":"Goodsaid","year":"2003","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9343(02)01529-2","article-title":"Troglitazone-induced liver failure: a case study","volume":"114","author":"Graham","year":"2003","journal-title":"Am. J. Med."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB4","first-page":"45","article-title":"An overview of toxicogenomics","volume":"4","author":"Hamadeh","year":"2002","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/em.10177","article-title":"cDNA microarray gene expression profiling of hydroxyurea, paclitaxel, and p-anisidine, genotoxic compounds with differing tumorigenicity results","volume":"42","author":"Lee","year":"2003","journal-title":"Environ. Mol. Mut."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB6","first-page":"183","article-title":"Toxicogenomics takes center stage","volume":"16","author":"Lehmann","year":"2003","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB7","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1289\/ehp.6028","article-title":"The comparative toxicogenomics database (CTD)","volume":"111","author":"Mattingly","year":"2003","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB8","first-page":"7","article-title":"Application of toxicogenomic analysis to risk assessment of delayed long-term effects of multiple chemicals, including endocrine disruptors in human fetuses","volume":"111","author":"Mori","year":"2003","journal-title":"EHP Toxicogenom."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0378-4274(02)00500-3","article-title":"Toxicogenomics: challenges and opportunities","volume":"140\u2013141","author":"Orphanides","year":"2003","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB10","doi-asserted-by":"crossref","first-page":"A20","DOI":"10.1289\/ehp.111t-a20","article-title":"Toxicogenomics: an emerging discipline","volume":"111","author":"Schmidt","year":"2003","journal-title":"EHP Toxicogenom."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/carcin\/23.6.903","article-title":"Toxicogenomics: the new frontier in risk analysis","volume":"23","author":"Simmons","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB12","first-page":"229","article-title":"The promise of toxicogenomics","volume":"4","author":"Waring","year":"2002","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1358\/dnp.2003.16.4.829333","article-title":"Application of toxicogenomics in drug development","volume":"16","author":"Gant","year":"2003","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0006-2952(02)01613-1","article-title":"Toxicogenomics of bromobenzene hepatotoxicity: a combined transcriptomics and proteomics approach","volume":"65","author":"Heijne","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1517\/14740338.1.3.275","article-title":"Toxicogenomics: an opportunity to optimise drug development and safety evaluation","volume":"1","author":"Kramer","year":"2002","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1586\/14737159.2.4.337","article-title":"Application of toxicogenomics to drug development","volume":"2","author":"Lakkis","year":"2002","journal-title":"Expert Rev. Mol. Diag."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nrd710","article-title":"Toxicogenomics and drug discovery: Will new technologies help us produce better drugs?","volume":"1","author":"Ulrich","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0009-2797(97)00071-9","article-title":"Primary human hepatocytes as a tool for the evaluation of structure\u2013activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin","volume":"107","author":"Li","year":"1997","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0009-2797(01)00162-4","article-title":"Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog","volume":"134","author":"Lu","year":"2001","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0009-2797(99)00081-2","article-title":"Present status of the application of cryopreserved hepatocytes in the evaluation of xenobiotics: consensus of an international expert panel","volume":"121","author":"Li","year":"1999","journal-title":"Chem. Biol. Interact."},{"issue":"Suppl. 3","key":"10.1016\/j.mrfmmm.2003.11.015_BIB21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1634\/theoncologist.7-suppl_3-34","article-title":"Cytotoxic agents in the era of molecular targets and genomics","volume":"7","author":"Chabner","year":"2002","journal-title":"Oncologist"},{"issue":"Suppl. 2","key":"10.1016\/j.mrfmmm.2003.11.015_BIB22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/026119290203002S21","article-title":"Genomics: an in vitro toxicology point of view","volume":"30","author":"Corvi","year":"2002","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB23","first-page":"53","article-title":"Development of a DNA microarray for toxicology based on hepatotoxin-regulated sequences","volume":"111","author":"Waring","year":"2003","journal-title":"EHP Toxicogenom."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB24","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1073\/pnas.93.9.4001","article-title":"P-Glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans","volume":"93","author":"Schuetz","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1006\/bbrc.1998.9662","article-title":"Modulation of MDR1 and CYP3A expression by dexamethasone: evidence for an inverse regulation in adrenals","volume":"252","author":"Seree","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jps.1173","article-title":"Investigation of the coordinated functional activities of cytochrome P450 3A4 and P-glycoprotein in limiting the absorption of xenobiotics in Caco-2 cells","volume":"91","author":"Tran","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1067\/mcp.2003.10","article-title":"Coordinate induction of both cytochrome P4503A and MDR1 by St. John\u2019s wort in healthy subjects","volume":"73","author":"Dresser","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/1354750031000070103","article-title":"Genomics and the search for novel biomarkers in toxicology","volume":"8","author":"Tugwood","year":"2003","journal-title":"Biomarkers"},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0009-2797(02)00051-0","article-title":"A review of the common properties of drugs with idiosyncratic hepatotoxicity and the \u201cmultiple determinant hypothesis\u201d for the manifestation of idiosyncratic drug toxicity","volume":"142","author":"Li","year":"2002","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archinte.163.6.728","article-title":"A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents","volume":"163","author":"Chan","year":"2003","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1089-3261(03)00020-5","article-title":"Hepatotoxicity of the thiazolidinediones","volume":"7","author":"Tolman","year":"2003","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1023\/A:1007451911843","article-title":"Applications of primary human hepatocytes in the evaluation of pharmacokinetic drug\u2013drug interactions: evaluation of model drugs terfenadine and rifampin","volume":"13","author":"Li","year":"1997","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1046\/j.1365-2125.1999.00081.x","article-title":"Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes","volume":"48","author":"Li","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0009-2797(99)00149-0","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in cultured rat and human hepatocytes","volume":"124","author":"Xu","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB35","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/jpet.102.041921","article-title":"Inhibition of transporter-mediated hepatic uptake as a mechanism for drug\u2013drug interaction between cerivastatin and cyclosporin A","volume":"304","author":"Shitara","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0009-2797(02)00055-8","article-title":"Correlation between troglitazone cytotoxicity and drug metabolic enzyme activities in cryopreserved human hepatocytes","volume":"142","author":"Hewitt","year":"2002","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.mrfmmm.2003.11.015_BIB37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0009-2797(02)00056-X","article-title":"Identification of glutathione conjugates of troglitazone in human hepatocytes","volume":"142","author":"Prabhu","year":"2002","journal-title":"Chem. Biol. Interact."}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510704000648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510704000648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T17:37:51Z","timestamp":1764697071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510704000648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0027510704000648"],"URL":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2003.11.015","relation":{},"ISSN":["1386-1964"],"issn-type":[{"value":"1386-1964","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrfmmm.2003.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}